Skip to content
Disclosery

ORBIMED ADVISORS LLC: XENE position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on XENE, newest first. How the timeline and the estimate are built.

ORBIMED ADVISORS LLC held 892,471 XENE shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 892,471 shares
    Change vs previous 13F -167,500 shares

    1.02% of the 13F portfolio, value $53,869,550.

    13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 1,059,971 shares
    Change vs previous 13F +612,771 shares

    1.34% of the 13F portfolio, value $61,637,314.

    13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 447,200 shares
    Change vs previous 13F +27,600 shares

    0.41% of the 13F portfolio, value $20,043,504.

    13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 419,600 shares
    Change vs previous 13F -528,277 shares

    0.4% of the 13F portfolio, value $16,846,940.

    13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 947,877 shares
    Change vs previous 13F 0 shares

    0.75% of the 13F portfolio, value $29,668,550.

    13F-HR 0001172661-25-003514 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 947,877 shares
    Change vs previous 13F 0 shares

    0.76% of the 13F portfolio, value $31,801,273.

    13F-HR 0001172661-25-002355 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 947,877 shares
    Change vs previous 13F +36,457 shares

    0.77% of the 13F portfolio, value $37,156,778.

    13F-HR 0001172661-25-001136 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 911,420 shares
    Change vs previous 13F not available

    0.66% of the 13F portfolio, value $35,882,605.

    13F-HR 0001172661-24-005167 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).